Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

BAHCC1 Inhibitors

BAHCC1 inhibitors are a class of chemical compounds that specifically target the BAHCC1 (Bromo Adjacent Homology Domain Containing 1) protein, a key player in chromatin remodeling and gene regulation. The BAHCC1 protein is involved in the regulation of gene expression through its ability to influence chromatin structure, a critical aspect of cellular function and identity. BAHCC1 acts as a molecular scaffold, interacting with various chromatin-related proteins and complexes to modulate the accessibility of specific genes. BAHCC1 inhibitors work by interfering with these interactions, preventing the protein from executing its normal functions in chromatin modification and gene regulation. This can lead to changes in the accessibility of certain genes, affecting their expression and altering broader cellular pathways related to transcriptional control.

BAHCC1 inhibitors are designed to be highly selective, often interacting with the specific domains of the BAHCC1 protein that are crucial for its function, such as the Bromo Adjacent Homology (BAH) domain. These inhibitors are typically small molecules, crafted to form stable interactions with the protein through various types of chemical bonding, including hydrogen bonds, hydrophobic contacts, and electrostatic interactions. The structural diversity of BAHCC1 inhibitors allows for fine-tuning of their affinity and specificity, enabling precise targeting of the protein's functional regions. Researchers in this field often focus on optimizing the solubility, stability, and bioavailability of these inhibitors to improve their performance in experimental systems. By studying the impact of BAHCC1 inhibitors on chromatin dynamics and gene expression, scientists can better understand the molecular functions of BAHCC1 and its role in regulating cellular processes like differentiation, proliferation, and genomic stability.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bisindolylmaleimide I (GF 109203X)

133052-90-1sc-24003A
sc-24003
1 mg
5 mg
$105.00
$242.00
36
(1)

This inhibitor targets protein kinase C (PKC), which is involved in numerous signaling pathways. By inhibiting PKC, this chemical can reduce phosphorylation events that are necessary for the activation of downstream proteins that may interact with BAH domain and coiled-coil containing 1, leading to its functional inhibition.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

As a potent inhibitor of the PI3K/Akt pathway, LY294002 prevents the phosphorylation and activation of Akt. Since Akt can regulate a broad spectrum of cellular processes, including those that might involve BAH domain and coiled-coil containing 1, its inhibition can lead to a decrease in the functional activity of BAH domain and coiled-coil containing 1.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

This chemical inhibits MEK1/2, which are upstream of the ERK pathway. Inhibition of MEK1/2 results in reduced ERK pathway signaling, which can affect cell cycle progression and differentiation processes that BAH domain and coiled-coil containing 1 may be involved in, thereby inhibiting its function.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is known to selectively inhibit p38 MAP kinase. The p38 MAPK pathway is involved in response to stress stimuli and cytokines, which can regulate proteins associated with BAH domain and coiled-coil containing 1, thus inhibiting its function indirectly by preventing activation of its associated signaling pathways.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

This compound selectively inhibits MEK, which is upstream of MAPK/ERK. By inhibiting the activation of ERK, PD98059 can disrupt cellular functions such as proliferation and differentiation that could be linked with BAH domain and coiled-coil containing 1 activity, leading to its functional inhibition.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is a covalent inhibitor of PI3K, which is critical for the PI3K/Akt signaling pathway. By inhibiting this pathway, wortmannin can hinder processes that may be crucial for BAH domain and coiled-coil containing 1 function, such as cellular metabolism and survival signals.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR, a key regulator of cell growth and proliferation. By inhibiting mTOR activity, rapamycin can decrease the overall protein synthesis and cellular metabolism which would indirectly inhibit the function of BAH domain and coiled-coil containing 1 by reducing its associated cellular processes.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

This chemical is an inhibitor of JNK, which plays a role in controlling gene expression and cell survival. Inhibition of JNK can alter transcriptional regulation and cellular stress responses that may indirectly inhibit BAH domain and coiled-coil containing 1's function in the cell.

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$94.00
$227.00
30
(1)

PP2 is a selective inhibitor of Src family tyrosine kinases. Src kinases can influence various signaling pathways that involve BAH domain and coiled-coil containing 1. By inhibiting Src kinases, PP2 can suppress these pathways, leading to functional inhibition of BAH domain and coiled-coil containing 1.

NF449

627034-85-9sc-478179
sc-478179A
sc-478179B
10 mg
25 mg
100 mg
$203.00
$469.00
$1509.00
1
(0)

NF449 is a potent and selective inhibitor of Gs-alpha subunit of G-proteins. G-proteins are involved in the regulation of a myriad of signaling pathways, and by inhibiting the Gs-alpha subunit, NF449 can suppress the signaling cascades that may regulate the function of BAH domain and coiled-coil containing 1.